Zepp Health Corp - CLASS A COMMON STOCK (ZEPP)

CUSIP: 98945L204

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / CLASS A COMMON STOCK
Shares outstanding
115,081,563
Total 13F shares
2,928,247
Share change
+1,447,898
Total reported value
$134,031,203
Put/Call ratio
66%
Price per share
$45.78
Number of holders
33
Value change
+$99,416,672
Number of buys
24
Number of sells
12

Quarterly Holders Quick Answers

What is CUSIP 98945L204?
CUSIP 98945L204 identifies ZEPP - Zepp Health Corp - CLASS A COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ZEPP - Zepp Health Corp - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Point72 Asset Management, L.P.
13D/G
7.6%
8,777,008
$401,805,282 +$105,511,398 30 Sep 2025
Allspring Global Investments Holdings, LLC
13D/G 13F
Company
2.9%
3,324,544
$172,211,379 -$333,209,094 30 Sep 2025
FIL Ltd
13F
Company
0.61%
704,254
$1,908,127 30 Jun 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.04%
42,554
$113,000 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.03%
31,796
$84,577 30 Jun 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.03%
29,697
$78,994 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
23,824
$63,372 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.01%
16,750
$44,555 30 Jun 2025
13F
Mandatum Life Insurance Co Ltd
13F
Company
0.01%
10,750
$28,595 30 Jun 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.01%
5,921
$14,000 30 Jun 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
3,125
$8,312 30 Jun 2025
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
1,145
$3,044 30 Jun 2025
13F
UBS Group AG
13F
Company
0%
1,098
$2,921 30 Jun 2025
13F
Rialto Wealth Management, LLC
13F
Company
0%
1,000
$2,660 30 Jun 2025
13F
SBI Securities Co., Ltd.
13F
Company
0%
726
$1,931 30 Jun 2025
13F
RHUMBLINE ADVISERS
13F
Company
0%
493
$1,310 30 Jun 2025
13F
JPMORGAN CHASE & CO
13F
Company
0%
231
$614 30 Jun 2025
13F
CITIGROUP INC
13F
Company
0%
173
$460 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
62
$165 30 Jun 2025
13F
MAI Capital Management
13F
Company
0%
53
$141 30 Jun 2025
13F

Institutional Holders of Zepp Health Corp - CLASS A COMMON STOCK (ZEPP) as of Q3 2025

As of 30 Sep 2025, Zepp Health Corp - CLASS A COMMON STOCK (ZEPP) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,928,247 shares. The largest 10 holders included Point72 Hong Kong Ltd, MORGAN STANLEY, Trivest Advisors Ltd, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, Allspring Global Investments Holdings, LLC, UBS Group AG, Balyasny Asset Management L.P., KEYSTONE INVESTORS PTE LTD, and MANUFACTURERS LIFE INSURANCE COMPANY, THE. This page lists 33 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
19
Q3 2025 holders
33
Holder diff
14
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .